Oct 21, 2026 07:33AM
Oct 15, 2026 06:57AM
Oct 14, 2026 11:20AM
Sep 1, 2026 09:07AM
Aug 4, 2026 07:38AM
Jul 30, 2026 04:53AM
Jun 1, 2026 01:53PM ImmunityBio to present cancer drug data at ASCO 2026 meeting
May 22, 2026 07:30AM
May 22, 2026 07:30AM
May 21, 2026 04:28PM
May 20, 2026 02:18PM
May 19, 2026 02:16PM
May 19, 2026 07:31AM
May 18, 2026 03:02PM $IBRX DEADLINE: Immunitybio Inc. Investors Who Lost Money Should Contact Block & Leviton Before May 26th Deadline
May 18, 2026 01:01PM
May 18, 2026 07:31AM
May 7, 2026 07:39AM
Apr 21, 2026 07:30AM
Apr 9, 2026 07:31AM
Apr 6, 2026 07:30AM
Mar 31, 2026 07:31AM ImmunityBio secures $100 million in financing with debt conversion
Mar 30, 2026 03:21PM
Mar 26, 2026 07:30AM
Mar 24, 2026 12:52PM
Mar 24, 2026 10:44AM
Mar 24, 2026 09:27AM
Mar 20, 2026 01:08PM
Mar 17, 2026 07:31AM NCCN updates bladder cancer guidelines to include ImmunityBio's ANKTIVA
Mar 13, 2026 07:30AM
Mar 11, 2026 04:11PM
Mar 9, 2026 07:31AM
Mar 4, 2026 07:54AM
Feb 26, 2026 07:31AM
Feb 25, 2026 03:09PM
Feb 23, 2026 01:03PM Immunitybio Inc (IBRX) PT Raised to $15 at H.C. Wainwright
Feb 23, 2026 10:39AM
Feb 23, 2026 08:17AM
Feb 23, 2026 07:01AM
Feb 20, 2026 08:30AM
Feb 19, 2026 09:02AM
Feb 18, 2026 09:01AM
Feb 17, 2026 06:09AM ImmunityBio discusses drug approvals with Saudi regulators
Jan 26, 2026 06:49AM
Jan 23, 2026 07:00AM
Jan 22, 2026 01:17PM
Jan 21, 2026 10:09AM
Jan 20, 2026 07:44AM
Jan 16, 2026 10:44AM
Jan 16, 2026 07:00AM ImmunityBio reports 15-month response in lymphoma cell therapy trial
Jan 16, 2026 07:00AM

470,801 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All